Richard Newitter

Q: What is Richard Newitter's success rate?

Richard Newitter currently has a success rate of 87.84715348096623.

Q: What is the average return of Richard Newitter's calls?

Their stock ratings have generated an average return of 7.348400988528588.

Truist Securities | Healthcare

Richard Newitter is an analyst from Truist Securities specializing in the Healthcare sector. Ranked #1820 out of 4582 analysts, they have issued 86 stock ratings with a success rate of 87.85% and an average return of 7.35%.

Richard Newitter has a well-established track record, with 86 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 87.85% and an average return of 7.35%, underscoring their expertise and ability to identify winning opportunities for investors.

#1820

Out of 4582

Total Ratings

+87.85%

Success Rate

+7.35%

Average Return

Recent Ratings Analysis

TNDM

Buy

Mar 19, 2026

Target

$35.00

Current

$24.63

Performance

0.00%

Richard Newitter rated TNDM as Buy on Mar 19, 2026, setting a price target of 35. Shares have remained stable near 24.63, leaving the 35 target still in play.

BSX

Buy

Mar 18, 2026

Target

$92.00

Current

$69.89

Performance

-1.95%

On Mar 18, 2026, BSX was given a Buy rating by Richard Newitter, with a target price of 92. The stock traded sideways with a -1.95% move, keeping the bullish thesis unresolved.

PRCT

Buy

Mar 02, 2026

Target

$47.00

Current

$25.68

Performance

-0.85%

PRCT received a Buy rating from Richard Newitter on Mar 02, 2026, aiming for 47. Price action was muted, as shares hovered around 25.68 despite the bullish outlook.

LNTH

Buy

Mar 02, 2026

Target

$89.00

Current

$77.99

Performance

2.21%

On Mar 02, 2026, Richard Newitter published a Buy outlook on LNTH, with a target of 89. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 77.99.

KIDS

Hold

Mar 02, 2026

Target

$20.00

Current

$16.54

Performance

-13.94%

Richard Newitter on Mar 02, 2026 assigned KIDS a Hold rating, with a price target of 20. The call successfully avoided chasing as shares lost 13.94%.

SIBN

Buy

Feb 24, 2026

Target

$24.00

Current

$12.77

Performance

-16.48%

On Feb 24, 2026, Richard Newitter reaffirmed SIBN with a Buy rating, targeting 24. Shares slid 16.48% despite the recommendation, highlighting downside risks.

IRTC

Buy

Feb 23, 2026

Target

$215.00

Current

$117.78

Performance

-16.60%

IRTC was rated Buy by Richard Newitter on Feb 23, 2026, with a price objective of 215. This case shows how bullish projections can fail, with the stock now below 117.78.

ITGR

Buy

Feb 20, 2026

Target

$97.00

Current

$84.36

Performance

-0.58%

On Feb 20, 2026, Richard Newitter initiated coverage on ITGR with a Buy rating and target of 97. Neutral price movement of -0.58% leaves room for interpretation.

PODD

Buy

Feb 19, 2026

Target

$390.00

Current

$228.63

Performance

-8.22%

Richard Newitter issued a Buy recommendation for PODD on Feb 19, 2026, price target set at 390. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

DXCM

Buy

Feb 17, 2026

Target

$82.00

Current

$67.27

Performance

-4.49%

On Feb 17, 2026, DXCM was evaluated by Richard Newitter, who gave a Buy rating and target of 82. So far, the Buy call awaits clearer momentum, with shares flat at 67.27.

INSP

Hold

Feb 12, 2026

Target

$96.00

Current

$54.68

Performance

-8.33%

Richard Newitter rated INSP as Hold on Feb 12, 2026, setting a price target of 96. The cautious Hold call aligned with subsequent weakness, as shares slipped 8.33%.

EW

Hold

Feb 11, 2026

Target

$92.00

Current

$82.46

Performance

3.95%

On Feb 11, 2026, EW was given a Hold rating by Richard Newitter, with a target price of 92. Market indecision, reflected in sideways trading near 82.46, supported the cautious call.

BBNX

Buy

Feb 02, 2026

Target

$25.00

Current

$10.80

Performance

-21.17%

BBNX received a Buy rating from Richard Newitter on Feb 02, 2026, aiming for 25. The rating hasn’t played out as hoped, with the stock trading 21.17% below expectations.

PEN

Hold

Jan 16, 2026

Target

$374.00

Current

$337.35

Performance

-3.83%

On Jan 16, 2026, Richard Newitter published a Hold outlook on PEN, with a target of 374. Sideways action left the Hold view intact, with no major move since 337.35.

SYK

Hold

Dec 18, 2025

Target

$400.00

Current

$339.76

Performance

—

Richard Newitter on Dec 18, 2025 assigned SYK a Hold rating, with a price target of 400. The Hold stance reflected consolidation, as shares held near 339.76.

VCEL

Buy

Dec 18, 2025

Target

$50.00

Current

$32.74

Performance

—

On Dec 18, 2025, Richard Newitter reaffirmed VCEL with a Buy rating, targeting 50. Market indecision has kept the 50 target in a holding pattern.

TMCI

Hold

Dec 18, 2025

Target

$4.00

Current

$1.31

Performance

—

TMCI was rated Hold by Richard Newitter on Dec 18, 2025, with a price objective of 4. Flat performance suggests the Hold view was reasonable.

GKOS

Buy

Dec 18, 2025

Target

$145.00

Current

$102.09

Performance

—

On Dec 18, 2025, Richard Newitter initiated coverage on GKOS with a Buy rating and target of 145. Neutral price movement of % leaves room for interpretation.

MDT

Hold

Dec 18, 2025

Target

$110.00

Current

$86.87

Performance

—

Richard Newitter issued a Hold recommendation for MDT on Dec 18, 2025, price target set at 110. The rating was appropriate for a consolidating market trading near 86.87.

ISRG

Buy

Dec 18, 2025

Target

$650.00

Current

$479.93

Performance

—

On Dec 18, 2025, ISRG was evaluated by Richard Newitter, who gave a Buy rating and target of 650. So far, the Buy call awaits clearer momentum, with shares flat at 479.93.

GMED

Buy

Nov 18, 2025

Target

$105.00

Current

$86.30

Performance

3.45%

Richard Newitter rated GMED as Buy on Nov 18, 2025, setting a price target of 105. Shares have remained stable near 86.3, leaving the 105 target still in play.

CARL

Buy

Nov 07, 2025

Target

$20.00

Current

$10.86

Performance

-20.50%

On Nov 07, 2025, CARL was given a Buy rating by Richard Newitter, with a target price of 20. Despite the Buy call, shares fell from 10.86 to 10.86, challenging the optimistic stance.

IART

Hold

Oct 15, 2025

Target

$15.00

Current

$8.90

Performance

-37.46%

IART received a Hold rating from Richard Newitter on Oct 15, 2025, aiming for 15. The Hold stance proved prudent, with the market softening by 37.46%.

TFX

Hold

Mar 03, 2025

Target

$149.00

Current

$107.05

Performance

-20.78%

On Mar 03, 2025, Richard Newitter published a Hold outlook on TFX, with a target of 149. Weakness in the stock, now at 107.05, supported the conservative rating.

ZBH

Hold

Feb 10, 2025

Target

$113.00

Current

$89.84

Performance

-10.54%

Richard Newitter on Feb 10, 2025 assigned ZBH a Hold rating, with a price target of 113. The call successfully avoided chasing as shares lost 10.54%.

NARI

Hold

Dec 18, 2024

Target

$63.00

Current

$79.97

Performance

45.32%

On Dec 18, 2024, Richard Newitter reaffirmed NARI with a Hold rating, targeting 63. Market strength beyond 79.97 went further than the conservative outlook suggested.

NVRO

Hold

Dec 18, 2024

Target

$4.70

Current

$5.84

Performance

56.15%

NVRO was rated Hold by Richard Newitter on Dec 18, 2024, with a price objective of 4.7. Despite caution, upside momentum rewarded risk-takers with gains to 5.84.

Frequency Asked Questions

Who is Richard Newitter?

Richard Newitter is an analyst from Truist Securities specializing in the Healthcare sector.

What is Richard Newitter's success rate?

Richard Newitter currently has a success rate of +87.85%.

How many ratings has Richard Newitter issued?

Richard Newitter has issued 86 stock ratings so far.

What is the average return of Richard Newitter's calls?

Their stock ratings have generated an average return of +7.35%.

What is Richard Newitter's ranking?

Richard Newitter is ranked #1820 out of 4582 analysts.

What types of ratings does Richard Newitter give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Richard Newitter?

You can follow Richard Newitter by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Richard Newitter?

Their latest rating was a Buy on TNDM issued on 2026-03-19.